Epidemiology, management, and survival of peritoneal carcinomatosis from colorectal cancer: A population-based study

Diseases of the Colon and Rectum

Volumn 58, Issue 8, 2015, Pages 743-752

  Quere, P ^a   Facy, O ^a   Manfredi, S ^b   Jooste, V ^a   Faivre, J ^a   Lepage, C ^a   Bouvier, A M ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b RENNES UNIVERSITY HOSPITAL   (France)

Author keywords

Cancer registry; Colorectal cancer; Metachronous metastasis; Peritoneal carcinomatosis; Synchronous metastasis

Indexed keywords

FLUOROURACIL; ANTINEOPLASTIC AGENT;

AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; COLORECTAL CARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SYSTEMIC THERAPY; ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; CARCINOMA; COLORECTAL NEOPLASMS; CYTOREDUCTIVE SURGERY; PATHOLOGY; PERITONEAL NEOPLASMS; PERITONEUM; PROGNOSIS; REGISTER; RETROSPECTIVE STUDY; SECONDARY; SURGERY; SURVIVAL RATE;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA; COLORECTAL NEOPLASMS; CYTOREDUCTION SURGICAL PROCEDURES; FEMALE; FRANCE; HUMANS; MALE; PERITONEAL NEOPLASMS; PERITONEUM; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84937679959     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0000000000000412     Document Type: Article

References (29)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLO BOCAN. 2008. Int J Cancer. 2010; 127: 2893-2917
2. Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 2006; 244: 254-259
3. Lemmens VE, Klaver YL, Verwaal VJ, Rutten HJ, Coebergh JW, de Hingh IH. Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study. Int J Cancer. 2011; 128: 2717-2725
4. Segelman J, Granath F, Holm T, Machado M, Mahteme H, Martling A. Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2012; 99: 699-705
5. van Gestel YR, Thomassen I, Lemmens VE, et al. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer. Eur J Surg Oncol. 2014; 40: 963-969
6. Elias D, Lefevre JH, Chevalier J, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol. 2009; 27: 681-685
7. Neo EL, Beeke C, Price T, et al. South Australian clinical registry for metastatic colorectal cancer. ANZ J Surg. 2011; 81: 352-357
8. Wang X, Hershman DL, Abrams JA, et al. Predictors of survival after hepatic resection among patients with colorectal liver metastasis. Br J Cancer. 2007; 97: 1606-1612
9. de Gramont A, Tournigand C, Louvet C, et al. Oxaliplatin, folinic acid and 5-fluorouracil (folfox) in pretreated patients with metastatic advanced cancer. The GERCOD [in French]. Rev Med Interne. 1997; 18: 769-775
10. Fritz A, Percy C, Jack A, et al. International Classification of Diseases for Oncology, 3rd ed. Geneva: World Health Organization; 2000
11. Wittekind CH, Wagner G, editors. Colon and rectum. In: Classification of Malignant Tumors, 5th ed. New York: Springer-Verlag; 1997: 64-67
12. Borrmann R. Geshwulste des Magens und Duodenums. In: Henke F, Lubarsch O, (eds): Handbuch des speziellen Pathologischen Anatomie und Histologie, vol 4. Berlin, Springer-Verlag, 1926; 865
13. Perme MP, Stare J, Estève J. On estimation in relative survival. Biometrics. 2012; 68: 113-120
14. Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med. 2004; 23: 51-64
15. Jayne DG, Fook S, Loi C, Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2002; 89: 1545-1550
16. Kerscher AG, Chua TC, Gasser M, et al. Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decades. Br J Cancer. 2013; 108: 1432-1439
17. Michelassi F, Vannucci L, Montag A, et al. Importance of tumor morphology for the long term prognosis of rectal adenocarcinoma. Am Surg. 1988; 54: 376-379
18. Steinberg SM, Barkin JS, Kaplan RS, Stablein DM. Prognostic indicators of colon tumors. The Gastrointestinal Tumor Study Group experience. Cancer. 1986; 57: 1866-1870
19. Favoulet P, Benoit L, Osmak L, et al. Prevention of peritoneal carcinomatosis from colon cancer cell seeding using a pirarubicin solution in rats and nude mice. World J Surg. 2004; 28: 451-456
20. Xie L, Villeneuve PJ, Shaw A. Survival of patients diagnosed with either colorectal mucinous or non-mucinous adenocarcinoma: a population-based study in Canada. Int J Oncol. 2009; 34: 1109-1115
21. Negri FV, Wotherspoon A, Cunningham D, Norman AR, Chong G, Ross PJ. Mucinous histology predicts for reduced fluorouracil responsiveness and survival in advanced colorectal cancer. Ann Oncol. 2005; 16: 1305-1310
22. Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003; 21: 3737-3743
23. Sugarbaker PH. Second-look surgery for colorectal cancer: revised selection factors and new treatment options for greater success. Int J Surg Oncol. 2011; 2011: 915078
24. Segelman J, Akre O, Gustafsson UO, Bottai M, Martling A. Individualized prediction of risk of metachronous peritoneal carcinomatosis from colorectal cancer. Colorectal Dis. 2014; 16: 359-367
25. Honoré C, Goéré D, Souadka A, Dumont F, Elias D. Definition of patients presenting a high risk of developing peritoneal carcinomatosis after curative surgery for colorectal cancer: a systematic review. Ann Surg Oncol. 2013; 20: 183-192
26. de Bree E, Koops W, Kröger R, van Ruth S, Witkamp AJ, Zoetmulder FA . Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement. J Surg Oncol. 2004; 86: 64-73
27. Jacquet P, Jelinek JS, Steves MA, Sugarbaker PH. Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer. 1993; 72: 1631-1636
28. Franko J, Shi Q, Goldman CD, et al. Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. JClin Oncol. 2012; 30: 263-267
29. Klaver YL, Simkens LH, Lemmens VE, et al. Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy. Eur J Surg Oncol. 2012; 38: 617-623